March 1, 2022
Gene-recombinant biotechnologies aim to produce key animal proteins at a fraction of the cost of conventional animal husbandry. The implications for research, medicine, food systems, and the climate could be huge. But can these emergent technologies scale quickly enough to spur system-wide change?
July 15, 2020
In 2040, one third of the meat on our plates could be grown outside of animals, drastically reducing the leading sources of CO2 emissions and water pollution, while answering the question of how to feed a global population of nine billion. Cellular agriculture companies such as Memphis Meats, BlueNalu, and Mosa Meat are racing to bring their products to market, but they are still missing a key ingredient: affordable culture media available in large quantities. Brussels-based startup Tiamat Sciences believes their technology platform could become the best option to bridge that gap.